Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Endocrinology
•
Bone and Calcium Disorders
•
Primary Care
Following abaloparatide use for osteoporosis treatment, how long do you consolidate with bisphosphonates before considering a drug holiday?
Answer from: at Community Practice
6 months
Sign In
or
Register
to read more
21202
Related Questions
What patient factors are most important when considering who needs a broader workup for osteoporosis prior to starting therapy?
How do you screen (imaging, modality) for bone density changes following oncologic treatment in childhood cancer survivors?
How do you approach the frequency of DEXA scan monitoring for older adults on bisphosphonate therapy during the course of therapy?
How do you approach osteoporosis screening in men?
How do you approach decision-making around initiation of osteoporosis therapy in patients with advanced dementia?
In patients with a history of retinal vein occlusion, how should the risk of recurrent thromboembolic events influence the selection of osteoporosis therapies?
How long can you delay the start of antiresorptive therapy after completion of anabolic therapy in patients with severe osteoporosis and recent invasive dental procedures?
How do you decide when to treat hypocalcemia in hospitalized patients?
Is the FRAX score reliable in assessing fracture risk for patients with history of prior bisphosphonate use?
Is there an evidence-based consensus on CT-derived Hounsfield unit thresholds for opportunistic assessment of osteoporosis, and how should such measurements be applied when DXA results are inconclusive or do not meet diagnostic criteria?